In recent experimental studies, we demonstrated a highly beneficial neuroprotective effect of
moderate-to high-dose human albumin treatment of transient focal cerebral ischemia, but we …

We have shown that high-concentration albumin therapy is markedly neuroprotective in
focal cerebral ischemia. The present study was conducted to ascertain the degree to which …

Background and Purpose—We examined the neuroprotective efficacy of moderate-dose
human albumin therapy in acute focal ischemic stroke and defined the therapeutic window …

Preclinical studies have recently shown that albumin has neuroprotective effects for stroke in
animal models. Thus, we sought to evaluate the effects of albumin therapy in patients with …

Treatment with human albumin administered intravenously in the immediate post-ischemic
period following a 2-h period of transient focal cerebral ischemia leads to a reduction of …

The purpose of this study was to determine whether treatment with high-dose human serum
albumin (HSA) would offer protection in a model of high-grade transient forebrain ischemia …

Background and Purpose—To study whether intravascular or hemodynamic factors
contribute to the marked neuroprotective effect of albumin therapy in focal cerebral ischemia …

Albumin is known to have neuroprotective effects. The protein has a long half-life circulation,
and its effects can therefore persist for a long time to aid in the recovery of brain ischemia. In …

Background and Purpose—We have recently shown high-dose human serum albumin
therapy to confer marked histological protection in experimental middle cerebral artery …

✓ The authors examined the effect of delayed high-concentration albumin therapy on
ischemic injury in a highly reproducible model of middle cerebral artery (MCA) occlusion in …